These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 1616664)

  • 1. High frequency of antibodies against recombinant HIV-2 Nef protein in HIV-2-positive and HIV-negative sera.
    Mayer J; Kienzle N; Ulrich R; Hunsmann G; Mueller-Lantzsch N
    AIDS; 1992 May; 6(5):519-20. PubMed ID: 1616664
    [No Abstract]   [Full Text] [Related]  

  • 2. Antibodies to recombinant HIV-1 nef protein detected in HIV-1 infection as well as in nonrisk individuals.
    Dis Markers; 1990; 8(4):226-7. PubMed ID: 1708319
    [No Abstract]   [Full Text] [Related]  

  • 3. Expression of the HIV-1 Nef protein in the baculovirus system: investigation of anti-Nef antibodies response in human sera and subcellular localization of Nef.
    Kienzle N; Enders M; Buck M; Siakkou H; Jahn S; Petzold G; Schneweis KE; Bachmann M; Müller WE; Müller-Lantzsch N
    Arch Virol; 1992; 126(1-4):293-301. PubMed ID: 1524496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epitopes of the HIV-1-negative factor (nef) reactive with murine monoclonal antibodies and human HIV-1-positive sera.
    Schneider T; Harthus HP; Hildebrandt P; Niedrig M; Bröker M; Weigelt W; Beck A; Pauli G
    AIDS Res Hum Retroviruses; 1991 Jan; 7(1):37-44. PubMed ID: 1707640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIV pathogenesis: Nef loses control.
    Foster JL; Garcia JV
    Cell; 2006 Jun; 125(6):1034-5. PubMed ID: 16777594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Persistent antibody response to the HIV-1-negative regulatory factor in HIV-1-infected seronegative persons.
    Ameisen JC; Guy B; Chamaret S; Loche M; Mach B; Tartar A; Mouton Y; Capron A
    N Engl J Med; 1989 Jan; 320(4):251-2. PubMed ID: 2783476
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparative analysis of HIV-1 and HIV-2 indeterminate western blot patterns.
    Ayisi NK; Aidoo M
    West Afr J Med; 1994; 13(3):164-7. PubMed ID: 7841107
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human immunodeficiency virus type 2 DNA vaccine provides partial protection from acute baboon infection.
    Locher CP; Witt SA; Ashlock BM; Polacino P; Hu SL; Shiboski S; Schmidt AM; Agy MB; Anderson DM; Staprans SI; zur Megede J; Levy JA
    Vaccine; 2004 Jun; 22(17-18):2261-72. PubMed ID: 15149785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibodies to HIV-1 nef(p27): prevalence, significance, and relationship to seroconversion.
    Cheingsong-Popov R; Panagiotidi C; Ali M; Bowcock S; Watkins P; Aronstam A; Wassef M; Weber J
    AIDS Res Hum Retroviruses; 1990 Sep; 6(9):1099-105. PubMed ID: 2265027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune responses to human immunodeficiency virus type 1 in exposed but uninfected individuals: protection or chance?
    Looney DJ
    J Clin Invest; 1994 Mar; 93(3):920. PubMed ID: 8132777
    [No Abstract]   [Full Text] [Related]  

  • 11. Antibodies to recombinant HIV-1 nef protein detected in HIV-1 infection as well as in nonrisk individuals.
    Ranki A; Järvinen K; Valle SL; Nurmilaakso P; Krohn K
    J Acquir Immune Defic Syndr (1988); 1990; 3(4):348-55. PubMed ID: 2179525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CTLs from lymphoid organs recognize an optimal HLA-A2-restricted and HLA-B52-restricted nonapeptide and several epitopes in the C-terminal region of HIV-1 Nef.
    Hadida F; Haas G; Zimmermann N; Hosmalin A; Spohn R; Samri A; Jung G; Debre P; Autran B
    J Immunol; 1995 Apr; 154(8):4174-86. PubMed ID: 7535824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of a new dot blot assay for confirmation of human immunodeficiency virus type 1 and 2 infections using recombinant p24, gp41, gp120 and gp36 antigens.
    Ravanshad M; Sabahi F; Mahboudi F; Kazemnejad A
    Saudi Med J; 2006 Jan; 27(1):31-6. PubMed ID: 16432590
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Purification and characterization of human immunodeficiency virus type 1 nef gene product expressed by a recombinant baculovirus.
    Matsuura Y; Maekawa M; Hattori S; Ikegami N; Hayashi A; Yamazaki S; Morita C; Takebe Y
    Virology; 1991 Oct; 184(2):580-6. PubMed ID: 1909480
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lack of anti-p27nef antibody detection in HIV-seronegative high-risk people.
    Gluckman JC; Fretz-Foucault C; Rouzioux C; Perret P; Lopez O; Bucquet D; Bahraoui E
    AIDS; 1989 Dec; 3(12):855-6. PubMed ID: 2517205
    [No Abstract]   [Full Text] [Related]  

  • 16. Therapeutic vaccination of HIV-1-infected patients on HAART with a recombinant HIV-1 nef-expressing MVA: safety, immunogenicity and influence on viral load during treatment interruption.
    Harrer E; Bäuerle M; Ferstl B; Chaplin P; Petzold B; Mateo L; Handley A; Tzatzaris M; Vollmar J; Bergmann S; Rittmaier M; Eismann K; Müller S; Kalden JR; Spriewald B; Willbold D; Harrer T
    Antivir Ther; 2005; 10(2):285-300. PubMed ID: 15865223
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Purification of an Escherichia coli-expressed Nef protein from the human immunodeficiency virus-type 2.
    Du Bois GC; Hodge DR; Hanson CA; Samuel KP; Zweig M; Showalter SD; Papas TS
    AIDS Res Hum Retroviruses; 1993 Dec; 9(12):1225-31. PubMed ID: 8142139
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibodies to the nef protein and to nef peptides in HIV-1-infected seronegative individuals.
    Ameisen JC; Guy B; Chamaret S; Loche M; Mouton Y; Neyrinck JL; Khalife J; Leprevost C; Beaucaire G; Boutillon C
    AIDS Res Hum Retroviruses; 1989 Jun; 5(3):279-91. PubMed ID: 2786420
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human immunodeficiency virus (HIV) nef-specific cytotoxic T lymphocytes in noninfected heterosexual contact of HIV-infected patients.
    Langlade-Demoyen P; Ngo-Giang-Huong N; Ferchal F; Oksenhendler E
    J Clin Invest; 1994 Mar; 93(3):1293-7. PubMed ID: 8132769
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Production of a nef-specific monoclonal antibody by the use of a synthetic peptide.
    De Santis R; Anastasi AM; Marcolini S; Valesini G; Pezzella M; Vonesch N; Sturchio E; Mele A
    AIDS Res Hum Retroviruses; 1991 Mar; 7(3):315-21. PubMed ID: 2064828
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.